NunaBio, the synthetic DNA spin out from Newcastle University, is proud to announce their successful certification to ISO 9001:2015.
ISO 9001 is an internationally recognized Quality Management Standard which ensures products and services meet the needs of clients through an effective Quality Management system.
Quality Manager Dr Steve Evans says
“ We have developed and implemented this system in order to improve our overall performance, maintain a high-level of quality and strong customer service, and provide a sound basis for sustainable development initiatives. Our decision to work towards ISO 9001 certification demonstrates a commitment to providing high-quality and consistent products and services to our clients and our ongoing investment in technology and development.”
CEO Joe Hedley comments
‘ISO 9001 is the basis of all of the ISO quality standards. To have achieved certification at such an early stage of the company’s development shows that we are operating in the right way to satisfy all regulatory requirements as we develop exciting new products.’
NunaBio is a privately owned life sciences company based in the northeast of the UK.
Founded in 2021, our multi-patented technology can quickly produce large quantities of pure synthetic DNA using environmentally conscious processes.
NunaBio’ platform enables the synthesis of whole genes and DNA fragments of unprecedented length without the use of plasmids or primers, which are existing bottlenecks in the synthetic biology industry. Our technology has broad applications across multiple areas of life sciences, including gene therapy, T cell engineering, viral vector synthesis, hybridisation capture and targeted biomarker panels.
Our mission is to enable game changing technologies across the life sciences and biotech sectors by providing novel high-quality material at scale – we are not only making products, we are empowering the most cutting-edge technologies to make an impact on the world.
